Tests:CA 125: Difference between revisions
Tests:CA 125
No edit summary |
No edit summary |
||
| (7 intermediate revisions by 4 users not shown) | |||
| Line 4: | Line 4: | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="2" | | ! colspan="2" | | ||
== Overview == | |||
|- | |- | ||
|Department | |Department | ||
| Line 15: | Line 16: | ||
|C125 | |C125 | ||
C-125 | C-125 | ||
C12-5 | C12-5 | ||
|- | |||
|Test Availability | |||
|Tested Monday, Wednesday and Friday afternoons. | |||
Please contact the laboratory if testing is required urgently | |||
|- | |- | ||
|Turnaround Time | |Turnaround Time | ||
| Line 21: | Line 27: | ||
|- | |- | ||
|Stability – Add test | |Stability – Add test | ||
| | |24 hours | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Specimen Requirements == | ||
|- | |- | ||
|Specimen | |Specimen | ||
|Serum | |Serum | ||
|- | |- | ||
|Preferred | |Preferred | ||
| | |<span style="background: #fbec5d"> Yellow-Top</span> SST or <span style="background:#e30022"> Red-Top </span> tube | ||
|- | |- | ||
|Acceptable | |Acceptable | ||
| | | | ||
|- | |||
|Unacceptable | |||
|Plasma | |||
|- | |- | ||
|Specimen Transportation | |Specimen Transportation | ||
| | | | ||
|- | |- | ||
| | |Paediatric Requirements | ||
|0.5 <span style="background:#e30022"> Red </span> microtainer | |0.5 mL <span style="background:#e30022"> Red </span> microtainer | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Aliquot Requirements == | ||
|- | |||
|Sample | |||
|Serum | |||
|- | |- | ||
| | |Preferred Volume | ||
|>500 uL | |>500 uL | ||
|- | |- | ||
|Minimum Volume | |Minimum Volume | ||
|200 uL | |200 uL | ||
|- | |- | ||
|Aliquot Transportation | |Aliquot Transportation | ||
|Samples should be separated from red cells within 24hrs of collection. | |Samples should be separated from red cells within 24hrs of collection. | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== Clinical Information == | |||
|- | |- | ||
|Reference Intervals | |Reference Intervals | ||
| Line 60: | Line 72: | ||
|- | |- | ||
|Test Method | |Test Method | ||
|Abbott | |Abbott Alinity i series analyser using Abbott reagents. Chemiluminescent microparticle immunoassay. | ||
|- | |- | ||
|Advanced Notice | |Advanced Notice | ||
| Line 70: | Line 80: | ||
| | | | ||
|- | |- | ||
! colspan="2" | | |||
== Comments == | |||
|- | |- | ||
| colspan="2" | | | colspan="2" |Used for monitoring Ovarian Carcinoma. | ||
Used for monitoring Ovarian Carcinoma. | |||
For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | ||
|} | |} | ||
{{DocMeta | |||
| owner = Crossley1 | |||
| review_ping = | |||
}} | |||
<!-- review-ping: 2026-09-14T07:57:57.920Z --> | |||